Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals

Study ID: NCT06750666
Start Date: 2025-12
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

480000

Intervention / Treatment

De-implementation of Urinary Dipsticks

Usual practice with no intervention

Sponsor

Jacob Bodilsen

Source: clinicaltrials.gov

Share:
Add to list

Investigating the Impact of a Patient-directed Coronary Artery Calcium Score Report

Study ID: NCT05359822
Start Date: 2026-06-01
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

7000

Intervention / Treatment

Image-Based Report

Sponsor

University Hospitals Cleveland Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Eating Disorder Chatbot Optimization

Study ID: NCT07218302
Start Date: 2026-03-01
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

800

Intervention / Treatment

Digital Chatbot Program

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

MDMA-assisted Therapy for Fibromyalgia

Study ID: NCT06066853
Start Date: 2026-01-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

MDMA

Sponsor

Spaulding Rehabilitation Hospital

Source: clinicaltrials.gov

Share:
Add to list

Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian Cities

Study ID: NCT07120477
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

500

Intervention / Treatment

Intravenous Esketamine

Crisis Response Planning intervention (structures safety planning)

Sponsor

University of Sao Paulo

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Study ID: NCT06290765
Start Date: 2026-02-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

70

Intervention / Treatment

Ropeginterferon alfa-2b

Phlebotomy and aspirin

Sponsor

PharmaEssentia

Source: clinicaltrials.gov

Share:
Add to list

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Study ID: NCT05764928
Start Date: 2026-01-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

BLEX 404

Sponsor

Rgene Corporation

Source: clinicaltrials.gov

Share:
Add to list

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

Study ID: NCT07128381
Start Date: 2026-01-31
End Date: 2033-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Axatilimab (SNDX-6352)

Ruxolitinib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis

Study ID: NCT04883619
Start Date: 2026-01-15
End Date: 2028-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Placebo

Nipocalimab

Standard-of-care treatment

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

Causal Mechanisms of Odor-Guided Behavior in Humans

Study ID: NCT07099092
Start Date: 2025-11-10
End Date: 2035-07-14
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

80

Intervention / Treatment

PIRC

TUS Amy

Sham

Sponsor

National Institute on Drug Abuse (NIDA)

Source: clinicaltrials.gov

Share:
Add to list